Search terms
Results 21 - 30 of 38 - ordered by :
Pages: 1 2 3 4

Department of Cardiology, Yeditepe University Hospital, Istanbul, Turkey Aims: This study aimed to evaluate the prognostic value of high-sensitivity C-reactive protein (hsCRP) during 10-year ...

Date : 20/06/2016 Item size : 35173 bytes

Noman A., Jesudason P., Egred M., Ahmed J. Aims: Stable coronary artery disease (CAD) has poorer prognosis when involving the left anterior descending artery (LAD). Baseline clinical and procedural ...

Date : 21/05/2013 Item size : 32505 bytes

EuroIntervention Safety, feasibility and effectiveness of TAVI in patients with severely impaired left ventricular systolic function: a single centre experience El-Mawardy M., Abdel-Wahab M., ...

Date : 21/05/2013 Item size : 33993 bytes

EuroIntervention In CABG patients with STEMI, treatment of occluded vein graft is associated with higher mortality rates compared to treatment of native coronary artery occlusion (10, 249 STEMI ...

Date : 21/05/2013 Item size : 34133 bytes

The overall in-hospital mortality rate was 4.5%; 4.3% in the routine-hours group and 4.6% in the out-of-hours group (odds ratio; 1.05, 95% Confidence Interval [CI]; 0.72-1.54, P=0.79). In the ...

Date : 15/05/2012 Item size : 32023 bytes

EuroIntervention Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with DES Pilgrim T., Kalesan B., Zanchin T., Pulver C., ...

Date : 15/05/2012 Item size : 32648 bytes

EuroIntervention Prior coronary artery bypass graft patients treated with primary PCI have higher long-term adverse event rates Papalia F., De Silva H.N., Jones D.A., Rathod K.S., Guttmann O., ...

Date : 15/05/2012 Item size : 32555 bytes

EuroIntervention Long-term outcome after PCI with DES compared to bare metal stents in saphenous vein graft lesions Aarhus University Hospital, Aalborg, Aalborg, Denmark Aims: The use of ...

Date : 15/05/2012 Item size : 33329 bytes

First-generation DES were used in 50.0% (of which 52.7% were sirolimus; 47.3% paclitaxel) and 50.0% had new-generation DES (78.5% everolimus; 11.8% zotorolimus; 9.7% biolimus). [...]there was no ...

Date : 15/05/2012 Item size : 32912 bytes

EuroIntervention Do hypoglycemia and hyperglycemia have an equal effect on all-cause mortality across the spectrum of coronary artery disease manifestations? Zhou Y.J., Yang S.W., Liu Y.Y., Zhao ...

Date : 15/05/2012 Item size : 33318 bytes